Sichuan Huiyu Pharmaceutical is an API and finished-dose manufacturer based in China. It holds 5 active US drug master files across a filed portfolio of 5 molecules. Its filings concentrate with NPRA (MY), UZPHARM (UZ) and MINSA (CR). Its GMP standing is certified by EMA and MHRA (UK).
| Site | FDA FEI |
|---|---|
| Neijiang, United Arab Emirates | Not on file |
| NEIJIANG, China | Not on file |
| Neijiang, China | Not on file |
| China, China | 3014500199 |
| Molecule | Regulators | Docs |
|---|---|---|
| Carfilzomib | US FDA | 1 |
| Etoposide | US FDA | 1 |
| Iron Sucrose | US FDA | 1 |
| Lanreotide | US FDA | 1 |
| Leucovorin Calcium | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| NPRA (MY) | 7 | None |
| UZPHARM (UZ) | 6 | None |
| MINSA (CR) | 3 | None |
| EDE (AE) | 3 | None |
| INVIMA (CO) | 1 | None |
| EMA | None | 3 |
| MHRA (UK) | None | 1 |
Choose your molecules and target markets. Sichuan Huiyu Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free